ORIGINAL RESEARCH article

Front. Bioeng. Biotechnol.

Sec. Tissue Engineering and Regenerative Medicine

Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1555983

Distribution and metabolism of iPSC-MSCs in the joint cavity of an osteoarthritis rat model

Provisionally accepted
Xiaoyang  YuanXiaoyang Yuan1Xulei  WangXulei Wang1,2Tian Xi  DuTian Xi Du2Feng  ZhangFeng Zhang1Gang  ChengGang Cheng1Kang  WangKang Wang1Haochen  XuHaochen Xu1Pingting  YangPingting Yang1Yan  ChangYan Chang1Wei  WeiWei Wei1Peng  HePeng He3*Shangxue  YanShangxue Yan1,2*
  • 1Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China
  • 2Laboratory Animal Center, Anhui Medical University, Hefei, Anhui Province, China
  • 3Department of Orthopedics, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China

The final, formatted version of the article will be published soon.

Preliminary study results show induced pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSCs), exhibit promising efficacy in an osteoarthritis rat model. However, the pharmacokinetics of iPSC-MSCs after injection into the knee joint are unknown, which limits further clinical applications.. The aim of this study was to investigate the therapeutic effects, the metabolism and distribution of iPSC-MSCs in the joint cavity of rats with knee osteoarthritis (KOA). The iPSC-MSCs labeled with the Antares2 luciferase gene were injected into the knee joints of rats, and then the metabolism and distribution of the cells in vivo were revealed by imaging and molecular biomarker methods. Histopathological results demonstrated that iPSC-MSCs significantly reversed joint tissue damage of arthritic rats. The fluorescence signal of iPSC-MSCs labeled with the Antares2 luciferase gene was stable and persistent with high detection sensitivity. The fluorescent signal duration of Antares2-iMSCs in the joint cavity of KOA rats was approximately 2 weeks, which was significantly longer than 1 week in the sham-operated group. The proportion of iPSC-MSCs in the synovial fluid gradually decreased over time, and for the first time, the cells were observed to attach to the synovium first, followed by the meniscus and cartilage. In conclusion, this study was the first to explore the metabolism and distribution of iPSC-MSCs after intra-articular injection by labeling the Antares2 luciferase gene, which provides assurance and a theoretical basis for the safety of clinical application of iPSC-MSCs in treating osteoarthritis.

Keywords: iPSC-MSCs, Antares2-iMSCs, Osteoarthritis, Metabolism, biodistribution

Received: 10 Jan 2025; Accepted: 04 Jun 2025.

Copyright: © 2025 Yuan, Wang, Du, Zhang, Cheng, Wang, Xu, Yang, Chang, Wei, He and Yan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Peng He, Department of Orthopedics, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China
Shangxue Yan, Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.